Patent · US Active

Resonance energy transfer assay with cleavage sequence and spacer

US8969016B2 · kind B2 · utility

10Cited by
4References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2012
Grant dateMar 3, 2015
Priority date
Expiry dateSep 24, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/952
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A molecular construct comprises a donor label, an acceptor label, a linker peptide disposed between the donor and the acceptor, the linker having a cleavage site sequence, and a spacer between at least one of (a) the donor and the cleavage site sequence and (b) the acceptor and the cleavage site sequence. Preferably, the construct is selected from the group consisting of CFP-(SGLRSRA)-SNAP-25-(SNS)-YFP, and CFP-(SGLRSRA)-synaptobrevin-(SNS)-YFP. In preferred embodiments, the linker peptide is a substrate of a botulinum neurotoxin selected from the group consisting of synaptobrevin (VAMP), syntaxin and SNAP-25, or a fragment thereof that can be recognized and cleaved by the botulinum neurotoxin. Advantageously, the spacer increases the electronic coupling between the donor label and the acceptor label relative to a corresponding construct without the spacer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.